At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 1,113 enrolled
Drug / intervention
conventional surgery +4 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Phase III Randomized Comparison of Radiotherapy Fractionation in Advanced Squamous Cell Carcinoma of the Head and Neck: Twice-Daily Hyperfractionation vs Split-Course Accelerated Hyperfractionation vs Accelerated Fractionation With Concomitant Boost vs Standard Fractionation
In Brief
A Phase 3 clinical trial evaluating conventional surgery, low-LET cobalt-60 gamma ray therapy, and 3 other interventions for Head and Neck Cancer. Completed, enrolled 1,113 participants.
Detailed Summary
RATIONALE: Patient abstract not available PURPOSE: Patient abstract not available
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHead and Neck Cancer
Countries--
CollaboratorsNational Cancer Institute (NCI)
Timeline
Phase 3CompletedFinished
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Primary CompletionAug 2002
First PostedOct 2008
Study CompletionNov 2013
TodayJul 2026
First PostedOct 13, 2008
Primary CompletionAug 1, 2002
Study CompletionNov 1, 2013
TodayJul 2, 2026
Posted 17.7 years ago
Interventions
conventional surgeryprocedure
low-LET cobalt-60 gamma ray therapyradiation
low-LET electron therapyradiation
low-LET photon therapyradiation
radiation therapyradiation